14-1-3169 U.S. Producer Questionnaire

OMB No. 3117-0016/USITC No. 14-1-3169; Expiration Date: 6/30/2014
(No response is required if currently valid OMB control number is not displayed)

U.S. PRODUCERS’ QUESTIONNAIRE
PERSULFATES FROM CHINA

This questionnaire must be received by the Commission by no later than October 21, 2013
See page 5 of the Instruction Booklet for filing instructions.
The information called for in this questionnaire is for use by the United States International Trade Commission in
connection with its review of the antidumping duty order concerning persulfates from China (Inv. No. 731-TA-749 (Third
Review)). The information requested in the questionnaire is requested under the authority of the Tariff Act of 1930, title
VII. This report is mandatory and failure to reply as directed can result in a subpoena or other order to compel the
submission of records or information in your firm’s possession (19 U.S.C. § 1333(a)).

Name of firm
Address
City

State

Zip Code

World Wide Web address
Has your firm produced persulfates (as defined in the instruction booklet) at any time since January 1, 2007?

NO

(Sign the certification below and promptly return only this page of the questionnaire to the Commission)

YES

(Read the instruction booklet carefully, complete all parts of the questionnaire, and return the entire
questionnaire to the Commission so as to be received by the date indicated above)

Return questionnaire via the U.S. International Trade Commission Drop Box by clicking
on the following link: https://dropbox.usitc.gov/oinv/. (use the following PIN: PERSR3)
CERTIFICATION
I certify that the information herein supplied in response to this questionnaire is complete and correct to the best of my knowledge
and belief and understand that the information submitted is subject to audit and verification by the Commission.
By means of this certification I also grant consent for the Commission, and its employees and contract personnel, to use the
information provided in this questionnaire and throughout this proceeding in any other import-injury proceedings or reviews
conducted by the Commission on the same or similar merchandise.
I acknowledge that information submitted in this questionnaire response and throughout this proceeding may be used by the
Commission, its employees, and contract personnel who are acting in the capacity of Commission employees, for developing or
maintaining the records of this proceeding or related proceedings for which this information is submitted, or in internal audits and
proceedings relating to the programs and operations of the Commission pursuant to 5 U.S.C. Appendix 3. I understand that all
contract personnel will sign non-disclosure agreements.

Name of Authorized Official

Title of Authorized Official

Date

Phone:
Signature

Email address
Fax:

Business Proprietary
U.S. Producers’ Questionnaire – Persulfates from China

Page 2

PART I.—GENERAL INFORMATION
The questions in this questionnaire have been reviewed with market participants to ensure that issues of
concern are adequately addressed and that data requests are sufficient, meaningful, and as limited as
possible. Public reporting burden for this questionnaire is estimated to average 50 hours per response,
including the time for reviewing instructions, searching existing data sources, gathering the data needed,
and completing and reviewing the questionnaire. Send comments regarding the accuracy of this burden
estimate or any other aspect of this collection of information, including suggestions for reducing the
burden, to the Office of Investigations, U.S. International Trade Commission, 500 E Street, SW,
Washington, DC 20436.
I-1a.

OMB statistics.--Please report below the actual number of hours required and the cost to your
firm of preparing the reply to this questionnaire and completing the form.
Hours

Dollars

I-1b.

OMB feedback.--We are interested in any comments you may have for improving this
questionnaire in general or the clarity of specific questions. Please attach such comments to your
firm’s response or send them to the above address.

I-2.

Establishments covered.--Provide the name and address of establishment(s) covered by this
questionnaire (see page 3 of the instruction booklet for reporting guidelines). If your firm is
publicly traded, please specify the stock exchange and trading symbol.

I-3.

Position regarding continuation of order.--Does your firm support or oppose continuation of
the antidumping duty order currently in place for persulfates from the following country?
Country
China

Support

Oppose

Take no position

Business Proprietary
U.S. Producers’ Questionnaire – Persulfates from China

Page 3

PART I.--GENERAL INFORMATION--Continued
I-4.

Ownership.--Is your firm owned, in whole or in part, by any other firm?
No

Yes--List the following information.

Firm name

I-5.

I-6.

Address

Extent of ownership
(e.g., percent of
ownership)

Related SUBJECT importers/exporters.--Does your firm have any related firms, either
domestic or foreign, that are engaged in importing persulfates from China into the United States
or that are engaged in exporting persulfates from China to the United States?
No

Yes--List the following information.

Firm name

Address

Affiliation

Related NONSUBJECT importers/exporters.--Does your firm have any related firms, either
domestic or foreign, that are engaged in importing persulfates from countries other than China
into the United States or that are engaged in exporting persulfates from countries other than China
to the United States?
No

Yes--List the following information.

Firm name and country

Address

Affiliation

Business Proprietary
U.S. Producers’ Questionnaire – Persulfates from China

Page 4

PART I.--GENERAL INFORMATION--Continued
I-7.

I-8.

Related producers.--Does your firm have any related firms, either domestic or foreign, that are
engaged in the production of persulfates?
No

Yes--List the following information.

Firm name

Address

Affiliation

Business plan.--In Parts II and IV of this questionnaire we request a copy of your company’s
business plan. Does your company or any related firm have a business plan or any internal
documents that describe, discuss, or analyze expected market conditions for persulfates?
No

Yes--Please provide the requested documents. If you are not providing the
requested documents, please explain why not.

Business Proprietary
U.S. Producers’ Questionnaire – Persulfates from China

Page 5

PART II.--TRADE AND RELATED INFORMATION
Further information on this part of the questionnaire can be obtained from Angela Newell
([email protected], 202-708-5409). Supply all data requested on a calendar-year basis.
II-1.

Contact information.-- Please identify the responsible individual and the manner by which
Commission staff may contact that individual regarding the confidential information submitted in
part II.
Name
Title
Email
Telephone
Fax

II-2.

Changes in operations.--Please indicate whether your firm has experienced any of the following
changes in relation to the production of persulfates since January 1, 2007.
(check as many as appropriate)
plant openings ..............................

plant closings................................

relocations ....................................

expansions ....................................

acquisitions...................................

consolidations...............................

prolonged shutdowns or
production curtailments................
revised labor agreements ..............

other (e.g., technology) ................

(please describe)

Business Proprietary
U.S. Producers’ Questionnaire – Persulfates from China

Page 6

PART II.--TRADE AND RELATED INFORMATION--Continued
II-3.

Anticipated changes in operations.--Does your firm anticipate any changes in the character of
your firm’s operations or organization (as noted above) relating to the production of persulfates in
the future?
No

II-4.

Yes--Supply details as to the time, nature, and significance of such changes
and provide underlying assumptions, along with relevant portions of
business plans or other supporting documentation that address this
issue. Include in your response a specific projection of your firm’s
capacity to produce persulfates (in 1,000 pounds) for 2013 and
2014.

Anticipated changes in operations in the event the order is revoked.--Would your firm
anticipate any changes in the character of your firm’s operations or organization (as noted above)
relating to the production of persulfates in the future if the antidumping duty order on persulfates
from China were to be revoked?
No

Yes--Supply details as to the time, nature, and significance of such changes
and provide underlying assumptions, along with relevant portions of
business plans or other supporting documentation that address this
issue. Include in your response a specific projection of your firm’s
capacity to produce persulfates (in 1,000 pounds) for 2013 and
2014.

Business Proprietary
U.S. Producers’ Questionnaire – Persulfates from China

Page 7

PART II.--TRADE AND RELATED INFORMATION--Continued
II-5.

Same equipment, machinery, and workers.--Has your firm since 2007 produced, or does your
firm anticipate producing in the future, other products on the same equipment and machinery
used in the production of persulfates and/or using the same production and related workers
employed to produce persulfates?
No

Yes--List the following information and report your firm’s combined
production capacity and production of these products and persulfates in
the periods indicated.

Product

Basis for allocation of capacity and
employment data (indicate if different)

Period

(Quantity in 1,000 pounds)
JanuarySeptember

Calendar year

Item
2007

2008

2009

2010

2011

2012

2012

2013

Overall Production Capacity
Production of:
Persulfates
Other product 1
Other product 2

II-6.

Constraints on production.--Please describe the constraint(s) that set the limit(s) on your firm’s
production capacity.

II-7.

Production shifting.--Is your firm able to switch production between persulfates and other
products in response to a relative change in the price of persulfates vis-à-vis the price of other
products, using the same equipment and/or labor?
No

Yes--Please identify the other products, the approximate time and cost
involved in switching, and the minimum relative price change required
for your firm to switch production to or from persulfates.

Business Proprietary
U.S. Producers’ Questionnaire – Persulfates from China

Page 8

PART II.--TRADE AND RELATED INFORMATION--Continued
II-8.

Trade data.--Report your firm’s production capacity, production, shipments, inventories, and
employment related to the production of persulfates in your firm’s U.S. establishment(s) during
the specified periods. (See definitions in the instruction booklet.)
Quantity (in 1,000 pounds) and value (in $1,000)
Calendar year
Item

2007

2008

2009

2010

January-September
2011

2012

2012

2013

Average production capacity1
(quantity) (A)
Beginning-of-period inventories
(quantity) (B)
Production (quantity) (C)
U.S. shipments:
Commercial shipments:
quantity (D)
value (E)
Internal consumption:2
quantity (F)
value (G)
Transfers to related firms:2
quantity (H)
value (I)
Export shipments:3
quantity (J)
value (K)
End-of-period inventories
(quantity) (L)
Channels of distribution:
U.S. shipments to distributors
(quantity) (M)
U.S. shipments to end users
(quantity) (N)
Employment data:
Average number of PRWs
(number) (O)
Hours worked by PRWs
(1,000 hours) (P)
Wages paid to PRWs (value)
(Q)
1

The production capacity (see definitions in instruction booklet) reported is based on operating
hours per week,
weeks per year. Please describe the methodology used to calculate production capacity, and explain any changes in
reported capacity (use additional pages as necessary).
2
Internal consumption and transfers to related firms should be valued at fair market value. In the event that your firm
uses a different basis for valuing these transactions, please specify that basis (e.g., cost, cost plus, etc.) and provide value
data using that basis for each of the periods noted above:

3

Identify your firm’s principal export markets:

.

Business Proprietary
U.S. Producers’ Questionnaire – Persulfates from China

Page 9

PART II.--TRADE AND RELATED INFORMATION--Continued
II-9.

Reconciliation of trade data.-(a)

Please note that the quantities reported in question II-8 should reconcile as follows in
each period (i.e., in each column):
Reconciliation
B+C–D–F–H–J=L
D+F+H=M+N

(b)

Do these data reconcile?
explain
Do these data reconcile?
explain

Yes

No--Please

Yes

No--Please

Please note that the quantities reported for end-of-period inventories should equal the
beginning-of-period inventories reported in the subsequent calendar year (i.e., line L of
year 2007 should equal line B of year 2008). Do these data reconcile for each adjacent
calendar year?
Yes.

No--Please explain.

II-10.

Transfers to related firms.--If your firm reported transfers to related firms in question II-8,
please indicate the nature of the relationship between your firm and the related firms (e.g., joint
venture, wholly owned subsidiary), whether the transfers were priced at market value or by a nonmarket formula, whether your firm retained marketing rights to all transfers, and whether the
related firms also processed inputs from sources other than your firm.

II-11.

Commercial shipments.--What share of your firm’s commercial shipments of persulfates was
used in each of the following end use applications in 2012?

End use applications
Cosmetics and pharmaceuticals
Electronics (e.g. printed circuit board etchants)
Environmental remediation
Oil and gas recovery
Polymerization applications (plastics, synthetic rubber, adhesives)
Pool and spa supply
Pulp and paper
Textiles
Other:

Share of
quantity of 2012
commercial
shipments
%
%
%
%
%
%
%
%
100 %

Business Proprietary
U.S. Producers’ Questionnaire – Persulfates from China

Page 10

PART II.--TRADE AND RELATED INFORMATION--Continued
II-12.

Purchases.--Other than direct imports, has your firm otherwise purchased persulfates since
January 1, 2007? (See definitions in the instruction booklet.)
No

Yes-- Please indicate the reasons for your firm’s purchases (if your firms’
reasons differ by source, please elaborate) and report the quantity and
value of such purchases below for the specified periods

Reasons:
(Quantity in 1,000 pounds, value in $1,000)
JanuarySeptember

Calendar year
Item

2007

2008

2009

2010

2011

2012

2012

2013

PURCHASES FROM U.S.
1
IMPORTERS OF
PERSULFATES FROM.—
China:
quantity
value
All other countries:
quantity
value
PURCHASES FROM
2
DOMESTIC PRODUCERS:
quantity
value
PURCHASES FROM OTHER
SOURCES:
quantity
Value
1
Please list the name of the importer(s) from which your firm purchased this product. If your firm’s suppliers differ
by source, please identify the source for each listed supplier.

2

Please list the name of the domestic producer(s) from which your firm purchased this product.

II-13.

Toll production.--Since January 1, 2007, has your firm been involved in a toll agreement (see
definition in the instruction booklet) regarding the production of persulfates?
No

II-14.

Yes--Name firm(s):

.

FTZ.--Does your firm produce persulfates in a foreign trade zone (FTZ)?
No

Yes--Identify FTZ(s):

.

Business Proprietary
U.S. Producers’ Questionnaire – Persulfates from China

Page 11

PART II.--TRADE AND RELATED INFORMATION--Continued
II-15.

Direct imports.--Since January 1, 2007, has your firm imported persulfates?
No

Yes--COMPLETE AND RETURN A U.S. IMPORTERS’
QUESTIONNAIRE

II-16.

Effect of order.--Describe the significance of the existing antidumping duty order covering
imports of persulfates from China in terms of its effect on your firm’s production capacity,
production, U.S. shipments, inventories, purchases, employment, revenues, costs, profits, cash
flow, capital expenditures, research and development expenditures, and asset values. You may
wish to compare your firm’s operations before and after the imposition of the order.

II-17.

Likely effect of revocation of order.--Would your firm anticipate any changes in its production
capacity, production, U.S. shipments, inventories, purchases, employment, revenues, costs,
profits, cash flow, capital expenditures, research and development expenditures, or asset values
relating to the production of persulfates in the future if the antidumping duty order on persulfates
from China were to be revoked?
No

Yes--Supply details as to the time, nature, and significance of such changes
and provide underlying assumptions, along with relevant portions of
business plans or other supporting documentation for any trends or
projections you may provide.

Business Proprietary
U.S. Producers’ Questionnaire – Persulfates from China

Page 12

PART III.--FINANCIAL INFORMATION
Address questions on this part of the questionnaire to Mary Klir ([email protected], 202-205-3247).
III-1.

Contact information.-- Please identify the responsible individual and the manner by which
Commission staff may contact that individual regarding the confidential information submitted in
part III.
Name
Title
Email
Telephone
Fax

III-2.

Accounting system.--Briefly describe your firm’s financial accounting system.
A.

When does your firm’s fiscal year end (month and day)?
If your firm’s fiscal year changed during the data-collection period, explain below:

B.1.

Describe the lowest level of operations (e.g., plant, division, company-wide) for which
financial statements are prepared that include persulfates:

2.

Does your firm prepare profit/loss statements for persulfates:
Yes
No
How often did your firm (or parent company) prepare financial statements (including
annual reports, 10Ks)? Please check relevant items below.
Audited,
unaudited,
annual reports,
10Ks,
10Qs,
Monthly,
quarterly,
semi-annually,
annually
Accounting basis:
GAAP,
cash,
tax, or
other comprehensive basis
of accounting (specify)

3.

4.

Note: The Commission may request that your company submit copies of its financial statements,
including internal profit-and-loss statements for the division or product group that includes
persulfates, as well as those statements and worksheets used to compile data for your firm’s
questionnaire response.

III-3.

Cost accounting system.--Briefly describe your firm’s cost accounting system (e.g., standard
cost, job order cost, etc.).

III-4.

Allocation basis.--Briefly describe your firm’s allocation basis, if any, for COGS, SG&A, and
interest expense and other income and expenses.

Business Proprietary
U.S. Producers’ Questionnaire – Persulfates from China

Page 13

PART III.--FINANCIAL INFORMATION--Continued
III-5.

Other products.--Please list any other products your firm produces in the facilities in which it
produces persulfates, and provide the share of net sales accounted for by these other products in
your firm’s most recent fiscal year:
Products

Share of sales
%
%
%
%
%

III-6.

Purchase inputs.--Does your firm purchase inputs (raw materials, labor, energy, or any other
services) used in the production of persulfates from any related firms?
Yes--Continue to question III-7 below.

III-7.

Inputs from related firms.--In the space provided below, identify the inputs used in the
production of persulfates that your firm purchases from related parties.
Input

III-8.

No--Continue to question III-9 below.

Related party

Inputs from related firms at cost.--All intercompany profit on inputs purchased from related
parties should be eliminated from the costs reported to the Commission in question III-10 (i.e.,
costs reported in question III-10 should only reflect the related party’s cost and not include an
associated profit component). Reasonable methods for determining and eliminating the
associated profit on inputs purchased from related parties are acceptable.
Has your firm complied with the Commission’s instructions regarding costs associated with
inputs purchased from related parties?
Yes

No

Business Proprietary
U.S. Producers’ Questionnaire – Persulfates from China

Page 14

PART III.--FINANCIAL INFORMATION--Continued
III-9.

Nonrecurring items (charges and gains) included in reported persulfates financial results.-For each annual and interim period for which financial results are reported in question III-10,
please specify all material (significant) nonrecurring items (charges and gains) in the schedule
below, the specific table III-10 line item where the nonrecurring items are included, a brief
description of the relevant nonrecurring items, and the associated values (in $1,000), as reflected
in table III-10; i.e., if an aggregate nonrecurring item has been allocated to table III-10, only the
allocated value amount included in table III-10 should be reported in the schedule below. Note:
The Commission’s objective here is to gather information only on material (significant)
nonrecurring items which impacted the reported persulfates financial results in table III-10.
JanuarySeptember

Fiscal years ended-2007
Nonrecurring item: In this column
please provide a brief description of each
nonrecurring item and indicate the
specific table III-10 line item where the
nonrecurring item is included.
1.
2.
3.
4.
5.
6.
7.

2008

2009

2010

2011

2012

2012

2013

Nonrecurring item: In these columns please report the amount (in $1,000) of the relevant
nonrecurring item reported in table III-10.

Business Proprietary
U.S. Producers’ Questionnaire – Persulfates from China

Page 15

PART III.--FINANCIAL INFORMATION--Continued
III-10A.Operations on persulfates.--Report the revenue and related cost information requested below on
the persulfates operations of your firm’s U.S. establishment(s).1 Do not report resales of
products. Note that internal consumption and transfers to related firms must be valued at
fair market value and purchases from related firms must be at cost.2 Provide data for your
firm’s six most recently completed fiscal years, and for the specified interim periods.
Quantity (in 1,000 pounds) and value (in $1,000)
Fiscal years ended-Item

2007

2008

2009

2010

2011

2012

3

Net sales quantities:
Commercial sales (“CS”)
Internal consumption (“IC”)
Transfers to related firms
(“Transfers”)
Total net sales quantities

0

0

0

0

0

0

0.0

0.0

0.0

0.0

0.0

0.0

0.0
0.0

0.0
0.0

0.0
0.0

0.0
0.0

0.0
0.0

0.0
0.0

0.0
0.0

0.0
0.0

0.0
0.0

0.0
0.0

0.0
0.0

0.0
0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Net sales values:3
Commercial sales
Internal consumption
Transfers to related firms
Total net sales values
4

Cost of goods sold (COGS):
Raw materials
Direct labor
Other factory costs
Total COGS
Gross profit or (loss)
Selling, general, and
administrative (SG&A)
expenses:
Selling expenses

General and administrative
expenses
Total SG&A expenses
Operating income (loss)
Other expenses and income:
Interest expense
All other expense items
All other income items
All other
expenses/(income), net
Net income or (loss) before
income taxes
Depreciation/amortization
included above
1

Include only sales (whether domestic or export) and costs related to your U.S. manufacturing operations.
Please eliminate any profits or (losses) on inputs from related firms pursuant question III-8.
3
Less discounts, returns, allowances, and prepaid freight. The quantities and values should approximate the corresponding
shipment quantities and values reported in Part II of this questionnaire.
4
COGS should include costs associated with CS, IC, and Transfers, as well as export shipments in question II-8.
2

Note -- The table above contains calculations that will appear when you have entered data in the MS
word form fields.

Business Proprietary
U.S. Producers’ Questionnaire – Persulfates from China

Page 16

PART III.--FINANCIAL INFORMATION--Continued
III-10A.Operations on persulfates.--Continued
Quantity (in 1,000) and value (in $1,000)
Item

January-September 2012

January-September 2013

3

Net sales quantities:
Commercial sales (“CS”)
Internal consumption (“IC”)
Transfers to related firms (“Transfers”)
Total net sales quantities

0

0

0.0

0.0

0.0
0.0

0.0
0.0

0.0
0.0

0.0
0.0

0.0
0.0

0.0
0.0

Net sales values:3
Commercial sales
Internal consumption
Transfers to related firms
Total net sales values
Cost of goods sold (COGS):4
Raw materials
Direct labor
Other factory costs
Total COGS
Gross profit or (loss)
Selling, general, and administrative
(SG&A) expenses:
Selling expenses
General and administrative expenses
Total SG&A expenses
Operating income (loss)
Other expenses and income:
Interest expense
All other expense items
All other income items
All other expenses/(income), net
Net income or (loss) before income taxes
Depreciation/amortization included above
1

Include only sales (whether domestic or export) and costs related to your U.S. manufacturing operations.
Please eliminate any profits or (losses) on inputs from related firms pursuant question III-8.
3
Less discounts, returns, allowances, and prepaid freight. The quantities and values should approximate the corresponding
shipment quantities and values reported in Part II of this questionnaire.
4
COGS should include costs associated with CS, IC, and Transfers, as well as export shipments in question II-8.
2

Note -- The table above contains calculations that will appear when you have entered data in the MS
word form fields.

Business Proprietary
U.S. Producers’ Questionnaire – Persulfates from China

Page 17

PART III.--FINANCIAL INFORMATION--Continued
III-10B. Financial data reconciliation.--The calculable line items from question III-10A (i.e., total net
sales quantities and values, total COGS, gross profit (or loss), total SG&A, and net income (or
loss)) have been calculated from the data submitted in the other line items. Do the calculated
fields return the correct data according to your firm's financial records ignoring non-material
differences that may arise due to rounding?
Yes

No.--If the calculated fields do not show the correct data, please double check the
feeder data for data entry errors and revise.
Also, check signs accorded to the post operating income line items; the two
expense line items should report positive numbers (i.e., expenses are positive
and incomes or reversals are negative--instances of the latter should be rare
in those lines) while the income line item also in most instances should have
its value be a positive number (i.e., income is positive, expenses or reversals
are negative).
If after reviewing and potentially revising the feeder data your firm has
provided, the differences between your records and the calculated fields
persist please identify and discuss the differences in the space below.

Business Proprietary
U.S. Producers’ Questionnaire – Persulfates from China

Page 18

PART III.--FINANCIAL INFORMATION--Continued
III-11. Asset values.--Report the total assets (i.e., both current and long-term assets) associated with the
production, warehousing, and sale of persulfates. If your firm does not maintain some or all of
the specific asset information necessary to calculate total assets for persulfates in the normal
course of business, please estimate this information based upon a method (such as production,
sales, or costs) that is consistent with your firm’s cost allocations in the previous question.
Provide data as of the end of your firm’s six most recently completed fiscal years.
Note: Total assets should reflect net assets after any accumulated depreciation and allowances deducted.
Total assets should be allocated to the subject products if these assets are also related to other products.
Please provide a brief explanation if there are any substantial changes in total asset value during the
period; e.g., due to asset write-offs, revaluation, and major purchases.
Value (in $1,000)
Fiscal years ended-2007

Item

2008

2009

2010

2011

2012

Total assets (net)

III-12. Capital expenditures and research and development expenses.--Report your firm’s capital
expenditures and research and development expenses on persulfates. Provide data for your firm’s
six most recently completed fiscal years, and for the specified interim periods.
Value (in $1,000)
Fiscal years ended-Item

2007

2008

2009

2010

January-September
2011

2012

2012

Capital expenditures
Research and development
expenses

III-13. Data consistency and reconciliation.--Please indicate whether your firm’s financial data for
questions III-10, 11, and 12 are based on a calendar year or your firm’s fiscal year:
Calendar year
Fiscal year (specify

)

Please note the quantities and values reported in question III-10 should reconcile with the data
reported in question II-8 (including export shipments) as long as they are reported on the same
calendar year basis.
Do these data in question III-10 reconcile with data in question II-8?
Yes

No--Please explain

2013

Business Proprietary
U.S. Producers’ Questionnaire – Persulfates from China

Page 19

PART IV.--PRICING AND MARKET FACTORS
Further information on this part of the questionnaire can be obtained from Aimee Larsen (202-205-3179,
[email protected])
Contact information.-- Please identify the responsible individual and the manner by which Commission
staff may contact that individual regarding the confidential information submitted in part IV.
Name
Title
Email
Telephone
Fax

PRICE DATA
IV-1.

This question requests quarterly quantity and value data, f.o.b. your firm’s U.S. point of
shipment, for your firm’s commercial shipments to unrelated distributors and end users since
2007 of the following products produced by your firm.
Product 1.—Potassium persulfates
Product 2.—Ammonium persulfates
Product 3.—Sodium persulfates

Please note that total dollar values should be f.o.b., U.S. point of shipment and should not include
U.S.-inland transportation costs. Total dollar values should reflect the final net amount paid to
your firm (i.e., should be net of all deductions for discounts or rebates). Also, please report pricing
separately for shipments to unrelated distributors and to unrelated end users. See instruction
booklet.

Business Proprietary
U.S. Producers’ Questionnaire – Persulfates from China

Page 20

PART IV.--PRICING AND MARKET FACTORS--Continued
IV-1a.

Pricing data (shipments to distributors).--Report below the quarterly price data1 for pricing
products2 produced and sold by your firm to unrelated distributors.

Report data in actual pounds and actual dollars (not 1,000s).
(Quantity in pounds, value in dollars)
Product 1
Product 2
Quantity
Value
Quantity
Value

Product 3
Period of shipment
Quantity
Value
2007:
January-March
April-June
July-September
October-December
2008:
January-March
April-June
July-September
October-December
2009:
January-March
April-June
July-September
October-December
2010:
January-March
April-June
July-September
October-December
2011:
January-March
April-June
July-September
October-December
2012:
January-March
April-June
July-September
October-December
2013:
January-March
April-June
July-September
1
Net values (i.e., gross sales values less all discounts, allowances, rebates, prepaid freight, and the value of
returned goods), f.o.b. your firm’s U.S. point of shipment.
2
Pricing product definitions are provided on the first page of Part IV.
Note.--If your firm’s product does not exactly meet the product specifications but is competitive with the specified
product, provide a description of the product. Also, please explain any anomalies in your firm’s reported pricing data.
Product 1:
Product 2:
Product 3:

Business Proprietary
U.S. Producers’ Questionnaire – Persulfates from China

Page 21

PART IV.--PRICING AND MARKET FACTORS--Continued
IV-1b. Pricing data (shipments to end users).--Report below the quarterly price data1 for pricing
products2 produced and sold by your firm to unrelated end users.
Report data in actual pounds and actual dollars (not 1,000s).
(Quantity in pounds, value in dollars)
Product 1
Product 2
Quantity
Value
Quantity
Value

Product 3
Period of shipment
Quantity
Value
2007:
January-March
April-June
July-September
October-December
2008:
January-March
April-June
July-September
October-December
2009:
January-March
April-June
July-September
October-December
2010:
January-March
April-June
July-September
October-December
2011:
January-March
April-June
July-September
October-December
2012:
January-March
April-June
July-September
October-December
2013:
January-March
April-June
July-September
1
Net values (i.e., gross sales values less all discounts, allowances, rebates, prepaid freight, and the value of
returned goods), f.o.b. your firm’s U.S. point of shipment.
2
Pricing product definitions are provided on the first page of Part IV.
Note.--If your firm’s product does not exactly meet the product specifications but is competitive with the specified
product, provide a description of the product. Also, please explain any anomalies in your firm’s reported pricing data.
Product 1:
Product 2:
Product 3:

Business Proprietary
U.S. Producers’ Questionnaire – Persulfates from China

Page 22

PART IV.--PRICING AND MARKET FACTORS--Continued
IV-2. Price setting.-- How does your firm determine the prices that it charges for sales of persulfates
(check all that apply)? If your firm issues price lists, please submit sample pages of a recent list.
Transaction
by
transaction

IV-3.

If other, describe

Annual
total
volume
discounts

No
discount
policy

Other

Describe

Pricing terms for persulfates.-(a)

What are your firm’s typical sales terms for its U.S.-produced persulfates?
Net 30
days

(b)

Net 60
days

2/10 net 30
days

Other

Other (specify)

On what basis are your firm’s prices of domestic persulfates usually quoted (check one)?
Delivered

IV-5.

Other

Discount policy.-- Please indicate and describe your firm’s discount policies (check all that
apply).

Quantity
discounts

IV-4.

Contracts

Set
price
lists

F.o.b.

If f.o.b., specify point

Contract versus spot.-- Approximately what share of your firm’s sales of its U.S.-produced
persulfates in 2012 was on a (1) long-term contract basis, (2) short-term contract basis, and
(3) spot sales basis?

Long-term contracts
(multiple deliveries for
more than 12 months)
Share of your
2012 sales

%

Type of sale
Short-term contracts
(multiple deliveries up
to and including 12
months)
%

Spot sales
(for a single
delivery)
%

Total
=100%

Business Proprietary
U.S. Producers’ Questionnaire – Persulfates from China

Page 23

PART IV.--PRICING AND MARKET FACTORS--Continued
IV-6.

Contract provisions.— Please fill out the table with respect to provisions of your firm’s typical
sales contracts for persulfates (or check “not applicable” if your firm does not sell on a long-term
and/or short-term contract basis).

Typical sales contract
provisions

Item

Average contract duration

Number of days

Price renegotiation (during the
contract period)

Yes

Short-term contracts

Long-term contracts

(multiple deliveries up to
and including 12 months)

(multiple deliveries for more
than 12 months)

No
Quantity

Fixed quantity and/or price

Price
Both
Yes

Meet or release provision

No

Not applicable

IV-7.

Lead times.--What is the average lead time between a customer’s order and the date of delivery
for your firm’s sales of your firm’s U.S.-produced persulfates?
Source
From inventory

%

Produced to order

%

Total

IV-8.

Share of
2012 sales

Lead time (days)

100 %

Shipping information.-(a)

What is the approximate percentage of the total delivered cost of persulfates that is
accounted for by U.S. inland transportation costs?
%

(b)

Who generally arranges the transportation to your firm’s customers’ locations?
your firm
purchaser (check one)

(c)

Indicate the approximate percentage of your firm’s sales of persulfates that are delivered
the following distances from your firm’s production facility.
Distance from production facility

Share

Within 100 miles

%

101 to 1,000 miles

%

Over 1,000 miles

%
Total

100

%

Business Proprietary
U.S. Producers’ Questionnaire – Persulfates from China

Page 24

PART IV.--PRICING AND MARKET FACTORS--Continued
IV-9. Geographical shipments.-- What is the geographic market area in the United States served by
your firm’s persulfates? (check all that apply)
Geographic area

√ if applicable

Northeast.–CT, ME, MA, NH, NJ, NY, PA, RI, and VT.
Midwest.–IL, IN, IA, KS, MI, MN, MO, NE, ND, OH, SD, and WI.
Southeast.–AL, DE, DC, FL, GA, KY, MD, MS, NC, SC, TN, VA, and WV.
Central Southwest.–AR, LA, OK, and TX.
Mountains.–AZ, CO, ID, MT, NV, NM, UT, and WY.
Pacific Coast.–CA, OR, and WA.
Other.–All other markets in the United States not previously listed, including AK, HI,
PR, and VI, among others.

IV-10. End uses.--List the end uses of the persulfates that your firm manufactures. For each end-use
product, what percentage of the total cost is accounted for by persulfates and other inputs?
Share of total cost of end use product
accounted for by
End use product

Persulfates (percent)

Other inputs (percent)

Total

%

%

100%

%

%

100%

%

%

100%

IV-11. Changes in end uses.--Have there been any changes in the end uses of persulfates since 2007?
Do you anticipate any future changes?
Changes in end
uses
Changes since
2007
Anticipated
changes

No

Yes

Explain

Business Proprietary
U.S. Producers’ Questionnaire – Persulfates from China

Page 25

PART IV.--PRICING AND MARKET FACTORS--Continued
IV-12. Substitutes.-- Can other products be substituted for persulfates?
No

Yes--Please fill out the table.

End use in which this
substitute is used

Substitute

Have changes in the price of this substitute
affected the price for persulfates?
No Yes

Explanation

1.
2.
3.

IV-13. Changes in substitutes.-- Have there been any changes in the number or types of products that
can be substituted for persulfates since 2007? Do you anticipate any future changes?
Changes in
substitutes

No Yes

Explain

Changes since
2007
Anticipated
changes

IV-14. Raw materials.-(a)

To what extent have changes in the prices of raw materials affected your firm’s selling
prices for persulfates since 2007?

(b)

Do you anticipate changes in your firm’s raw material costs in the foreseeable future?
No

Yes

If yes, please identify the source and the grade/type/size.

Business Proprietary
U.S. Producers’ Questionnaire – Persulfates from China

Page 26

PART IV.--PRICING AND MARKET FACTORS--Continued
IV-15. Changes in factors affecting supply.--Have any changes occurred in any other factors affecting
supply (e.g., changes in availability or prices of energy or labor; transportation conditions;
production capacity and/or methods of production; technology; export markets; or alternative
production opportunities) that affected the availability of U.S.-produced persulfates in the U.S.
market since 2007?

No

Yes

If yes, please note the time period(s) of any such changes, the factors(s)
involved, and the impact such changes had on your firm’s shipment
volumes and prices.

IV-16. Availability of supply (U.S.-produced).--Do you anticipate any changes in terms of the
availability of U.S.-produced persulfates in the U.S. market in the future?
No
Increase change Decrease If you anticipate changes in supply, please explain.

IV-17. Availability of supply (nonsubject).--Has the availability of NONSUBJECT persulfates (i.e.,
persulfates imported from countries other than China) changed since 2007?
No

Yes

If yes, please explain.

IV-18. Export constraints.--Describe how easily your firm can shift its sales of persulfates between the
U.S. market and alternative country markets. In your discussion, please describe any contracts,
other sales arrangements, or other constraints that would prevent or retard your firm from shifting
persulfates between the U.S. and alternative country markets within a 12-month period.

Business Proprietary
U.S. Producers’ Questionnaire – Persulfates from China

Page 27

PART IV.--PRICING AND MARKET FACTORS--Continued
IV-19. Product changes.-- Have there been any significant changes in the product range, product mix,
or marketing of persulfates since 2007? Do you anticipate any future changes?
Changes in
product range,
product mix, or
marketing
No Yes

Explain

Changes since
2007
Anticipated
changes

IV-20. Demand trends.-- Indicate how demand within the United States and outside of the United States
(if known) for persulfates has changed since January 1, 2007, and how you anticipate demand
will change in the future. Explain any trends and describe the principal factors that have affected,
and that you anticipate will affect, these changes in demand.

Market

Overall
No
increase change

Fluctuate
Overall
with no
decrease clear trend
Demand since 2007

Within
the United
States
Outside
the United
States
Anticipated future demand
Within
the United
States
Outside
the United
States

Explanation and factors

Business Proprietary
U.S. Producers’ Questionnaire – Persulfates from China

Page 28

PART IV.--PRICING AND MARKET FACTORS--Continued
IV-21. Conditions of competition.-(a) Is the persulfates market subject to business cycles (other than general economy-wide
conditions) and/or other conditions of competition distinctive to persulfates?
No (skip to question IV-22).
Yes-Business cycles (e.g. seasonal business).
Yes-Other distinctive conditions of competition.
If yes, describe below.
Business cycles
Other conditions
of competition

(b) If yes, have there been any changes in the business cycles or conditions of competition for
persulfates since January 1, 2007?
No

Yes

If yes, please describe.

IV-22. Price comparisons.--Please compare market prices of persulfates in U.S. and non-U.S. markets,
if known. Provide specific information as to time periods and regions for any price comparisons.

IV-23. Market studies.--Please provide as a separate attachment to this request any studies, surveys, etc.
that you are aware of that quantify and/or otherwise discuss persulfates supply (including
production capacity and capacity utilization) and demand in (1) the United States, (2) each of the
other major producing/consuming countries, including China, and (3) the world as a whole. Of
particular interest is such data from 2007 to the present and forecasts for the future.
IV-24. Barriers to trade.--Are your firm’s exports of persulfates subject to any tariff or non-tariff
barriers to trade in other countries?

No

Yes

If yes, please list the countries and describe any such barriers and any
significant changes in such barriers that have occurred since 2007, or
that are expected to occur in the future.

Business Proprietary
U.S. Producers’ Questionnaire – Persulfates from China

Page 29

PART IV.--PRICING AND MARKET FACTORS--Continued
IV-25. Interchangeability.--Are persulfates produced in the United States and in other countries
interchangeable (i.e., can they physically be used in the same applications)?
Please indicate A, F, S, N, or 0 in the table below:
A = the products from a specified country-pair are always interchangeable
F = the products are frequently interchangeable
S = the products are sometimes interchangeable
N = the products are never interchangeable
0 = no familiarity with products from a specified country-pair
Country-pair

China

Other countries

United States
China

For any country-pair producing persulfates that is sometimes or never interchangeable, please
explain the factors that limit or preclude interchangeable use:

Business Proprietary
U.S. Producers’ Questionnaire – Persulfates from China

Page 30

PART IV.--PRICING AND MARKET FACTORS--Continued
IV-26. Factors other than price.--Are differences other than price (i.e., quality, availability,
transportation network, product range, technical support, etc.) between persulfates produced in
the United States and in other countries a significant factor in your firm’s sales of the products?
Please indicate A, F, S, N, or 0 in the table below:
A = such differences are always significant
F = such differences are frequently significant
S = such differences are sometimes significant
N = such differences are never significant
0 = no familiarity with products from a specified country-pair
Country-pair

China

Other countries

United States
China

For any country-pair for which factors other than price always or frequently are a significant
factor in your firm’s sales of persulfates, identify the country-pair and report the advantages or
disadvantages imparted by such factors: